Company intelligence / Profile preview

Kinnos

New York, New York, United States

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Kinnos commercializes Highlight, a patented color additive and wipe-colorizing technology that temporarily tints disinfectants so users can visually confirm complete surface coverage; studies in hospital settings have shown improvements in cleaning quality metrics of up to ~70–95% when Highlight is used with standard disinfectants.[1][2][3]

Therapeutic areas: Infectious Diseases
Modalities: DeviceNon-pharmacological therapy
Industry: Consumable Medical Devices

Partnerships

Humanitarian and NGO deployments in Liberia, Guinea, Haiti, DR Congo and Uganda for outbreak response[1][3]

Beyond the preview

Go deeper on Kinnos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinnos.

Explore the full profile